Your web browser is out of date. Update your browser for more security, speed and the best experience on this site.

Update your browser
DPR Construction Logo
Exterior view from road of UCSF regeneration medicine building.

University of California, San Francisco Regeneration Medicine Building

University of California, San Francisco Regeneration Medicine Building | San Francisco, California

DPR, along with design/build team members SmithGroup and Forell/Elsesser Engineers, developed and constructed this $91 million, 67,000-sq.-ft. design/build project, which achieved LEED Gold.

Perched on the steeply rolling hillside of University of California, San Francisco's (UCSF) Parnassus campus, the new green research facility supports 24 UCSF scientists and their teams in their goal to understand the basic biology of stem cells and to translate those discoveries into medical therapies for presently incurable diseases and debilitating injuries.

Seismically Sound

In addition to advancing the emerging field of stem cell research, the project utilized the latest design and construction tools and methodology, including building information modeling (BIM) and integrated project delivery (IPD). The core team took an integrated approach for this momentous project, drawing upon the principles of lean construction and used BIM technologies to meet the schedule and budget and deliver a world-class green facility for breakthrough scientific research.

This project, designed by renowned New York architect Rafael Viñoly, was one of 12 planned facilities in California awarded funds by CIRM's governing board, under a competitive two-stage application process that initially included 17 applications. The facility features wet laboratories, as well as laboratory support and office spaces, located on a series of split-level floors with terraced grass green roofs. The building is base isolated and seismically designed to move a maximum of 26 inches laterally during a significant earthquake with little or no damage.

We think you'll like this, too.
Related Content